NOVT at a glance
NOVANTA INC (NOVT, SEC CIK 1076930) filed its latest 10-K annual report on February 23, 2026, a 10-Q quarterly report on November 9, 2026, an 8-K current report on November 9, 2026 and Form 4 insider filings as recently as November 5, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), NOVANTA INC (NOVT) reported revenue of $980.6 million (up 3.3% from FY2024) and net income of $53.8 million. Diluted EPS was $1.47.
- As of September 30, 2026, 33 institutional investment managers tracked by SignalX reported holding NOVANTA INC (NOVT) shares worth $2.6 billion in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by Secor Thomas N on September 11, 2026 of 663 shares at $147.60 per share.
- In the last 90 days, NOVT insiders reported 0 open-market purchases ($0) and 1 open-market sale ($98K) on Form 4, a net sale of $98K.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $980.6M
- +3.3% vs prior year
- Insiders · 90 days
- 0 buys · 1 sell
- Net −$98K
- 13F holders
- 33 funds
- $2.6B · −3 vs prior quarter
- Latest 8-K
- Nov 9, 2026
- Item 2.02
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Business Overview
- Core business: Supplier of proprietary technology solutions for medical, life science, and advanced industrial OEMs focused on precision and performance
- New emphasis on RFID solutions through acquisition of Keonn Technologies for €64.8M ($71.0M), included in Medical Solutions segment
- Strategic shift: Increased focus on growing medical sales percentage, targeting minimally invasive and robotic surgery, ophthalmology, and life science applications
- Key metric: Consolidated backlog increased to $481.2M from $445.5M, signaling stronger demand pipeline
- Noteworthy event: Issued 12.65M tangible equity units raising net proceeds of $613.1M for growth and capital deployment
Risk Factors
- Regulatory/legal risk: Restrictions on dividends and asset transfers from foreign subsidiaries under local laws impacting funding for parent operations
- Geopolitical/macro risk: $67.6M cash and $74M debt held by non-North American subsidiaries, limiting capital repatriation flexibility
- Operational/supply chain risk: Higher inventory levels due to regionalized manufacturing strategy reducing 2025 operating cash flow to $64.1M from $158.5M in 2024
- Competitive/market disruption risk: Share repurchase plans open to market fluctuations, with $200M authorization in 2025 but no repurchases yet, risking shareholder dilution management
- Financial/structural risk: $632.5M tangible equity units issued with $110.6M amortizing notes outstanding, bearing 6.30% interest and $33.6M estimated future interest on senior credit facilities
AI summary of the NOVT 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Oct 2, 2026
Risk Factors
- Newly added geopolitical risk: February 2026 U.S.-Israel-Iran conflict increased energy, freight and commodity costs
- Most material acquisition risk: Riverpoint Medical purchase for $1,200.6 million heightened integration and impairment exposure
- Regulatory risk: Chinese export-license restrictions delayed rare-earth material shipments and customer order fulfillment
- Operational risk: Limited or single-source components could cause missed shipments and permanent customer-order losses
- Financial risk: Total debt increased to $838.6 million as of October 2, 2026, raising variable-rate exposure
Management Discussion & Analysis
- Revenue $305.0M, up $57.2M or 23.1% YoY, including $32.9M from the 2026 acquisition
- Total gross margin 44.5% vs 44.8% YoY, operating margin 4.6% vs 8.8% YoY
- Best segment Automation Enabling Technologies: revenue $145.4M, up 16.0%, operating margin 28.1% vs 21.8%
- Worst segment Medical Solutions margin: operating margin 6.0% vs 13.0%, gross margin 39.9% vs 43.0%
- Cash $149.2M vs $380.9M, operating cash flow $155.9M, acquisition investment $1,200.6M, 2026 capex outlook $30M to $40M
AI summary of the NOVT 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Novanta announced fiscal Q3 2026 financial results for the quarter ended October 2, 2026
- Investor-relevant revenue, earnings and outlook details are in Exhibit 99.1, the accompanying earnings release
Item EX-99.1: Item EX-99.1
- Q3 revenue $305.0M, up 23.1%, with 9.9% organic growth and $32.9M acquisition contribution
- Adjusted EBITDA $80.3M, up 38.3%, margin 26.3% versus 23.4%, signaling operating leverage
Item EX-99.3: Item EX-99.3
- Transaction closed July 23, 2026 for $1,450.6M, including $244.1M fair-valued milestone payable by January 8, 2027
- Funding included $616.0M debt and $287.6M net equity proceeds, materially increasing leverage and share count
Item EX-99.1: Item EX-99.1
- Audited 2025 financials for Riverpoint Medical, the business owned by Runway Buyer, LLC, support SEC acquisition-reporting requirements
- Revenue $136.1M and net income $11.5M, indicating a profitable medical-device target
Item EX-99.2: Item EX-99.2
- Runway Buyer generated $33.5M revenue and $2.4M net income in Q1 2026
- Operating income $7.5M, offset by $4.5M interest expense and 20.8% effective tax rate
Item 2.02: Results of Operations and Financial Condition
- Fiscal quarter ended July 3, 2026 results announced
- Novanta’s press release contains the financial performance details investors need
Item EX-99.1: Item EX-99.1
- Q2 revenue rose 10.3% to $265.8M, with organic growth of 9.3%, indicating broad-based underlying demand
- Adjusted EBITDA increased 16.4% to $60.7M, expanding margin to 22.8% from 21.6%
AI summaries of NOVT 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for NOVT
Don't miss the next NOVT filing
- Alerts as it files. A push when NOVT files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut NOVT, by share count.
- Ask anything. An AI agent that reads every NOVT filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| FARRELL MATTHEW | M | Nov 3, 2026 | 241 | - |
| FARRELL MATTHEW | M | Nov 3, 2026 | 241 | - |
| Secor Thomas N | Sell | Sep 11, 2026 | 663 | $147.60 |
| Glastra Matthijs | Sell | Jul 2, 2026 | 437 | $163.71 |
| Glastra Matthijs | Sell | Jul 2, 2026 | 1,167 | $162.01 |
| Glastra Matthijs | Sell | Jul 2, 2026 | 1,167 | $162.01 |
| Glastra Matthijs | Sell | Jul 2, 2026 | 3,024 | $160.13 |
| Glastra Matthijs | Sell | Jul 2, 2026 | 437 | $163.71 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $949.2M | $980.6M |
| Gross Profit | - | $421.5M | $435.3M |
| Operating Income | - | $110.6M | $94.0M |
| Net Income | - | $64.1M | $53.8M |
| Gross Margin | - | 44.4% | 44.4% |
| Op. Margin | - | 11.6% | 9.6% |
| Net Margin | - | 6.8% | 5.5% |
| Balance Sheet | |||
| Total Assets | $1.2B | $1.4B | $1.8B |
| Equity | $673.5M | $745.7M | $1.3B |
| ROE | - | 8.6% | 4.1% |
| Per Share | |||
| EPS | - | $1.77 | $1.47 |
| Cash Flow | |||
| Operating CF | - | $158.5M | $64.1M |
| CapEx | - | $17.2M | $15.6M |
Source: XBRL data in NOVANTA INC (NOVT)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate NOVT share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 33 | $2.58B |
| Q2 2026 | 36 | $2.90B |
| Q1 2026 | 31 | $1.90B |
| Q4 2025 | 29 | $1.81B |
| Q3 2025 | 30 | $1.63B |
| Q2 2025 | 30 | $2.11B |
| Q1 2025 | 27 | $1.23B |
| Q4 2024 | 25 | $1.22B |
- Goldman Sachs Group+516.7K (+137%)
- Invesco Ltd+250.7K (+61%)
- BlackRock+133.3K (+3%)
- Vanguard Capital Management LLC+90.2K (+6%)
- State Street Corp+43.3K (+3%)
- Citadel Advisors LLC−290.0K (-93%)
- T. Rowe Price Group−167.1K (-8%)
- JPMorgan Chase & Co−96.0K (-14%)
- Principal Financial Group−92.0K (-41%)
- Ameriprise Financial−68.0K (-38%)
- Blackstone Group−60.0K
- FMR LLC (Fidelity)−14.6K
- PARK NATIONAL CORP /OH/−1.3K
Source: 13F-HR filings on SEC EDGAR (aggregated from 241 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
NOVT filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 10-Q | Nov 9, 2026 | Oct 2, 2026 | Analysis | |
| 8-K | Nov 9, 2026 | - | Analysis | - |
| 4 | Nov 5, 2026 | - | - | - |
| 8-K | Oct 2, 2026 | - | Analysis | - |
| 4 | Sep 15, 2026 | - | - | - |
| 8-K | Aug 5, 2026 | - | Analysis | - |
| 10-Q | Aug 5, 2026 | Jul 3, 2026 | Analysis | |
| 8-K | Jul 27, 2026 | - | Analysis | - |
| 4 | Jul 7, 2026 | - | - | - |
| 8-K | Jun 9, 2026 | - | Analysis | |
| 8-K | Jun 9, 2026 | - | Analysis | |
| 4 | Jun 4, 2026 | - | - | |
| 8-K | May 29, 2026 | - | Analysis | |
| 8-K | May 15, 2026 | - | Analysis | |
| 10-Q | May 11, 2026 | Apr 3, 2026 | Analysis | |
| 8-K | May 11, 2026 | - | Analysis | |
| 4 | May 7, 2026 | - | - | |
| SC 13G | Apr 30, 2026 | - | - | |
| SC 13G | Apr 29, 2026 | - | - | |
| 4 | Apr 21, 2026 | - | - | - |
| 4 | Mar 18, 2026 | - | - | - |
| 4 | Mar 4, 2026 | - | - | - |
| 4 | Feb 26, 2026 | - | - | - |
| 4 | Feb 26, 2026 | - | - | - |
| 4 | Feb 26, 2026 | - | - | - |
Related Information Technology companies
- BYRN · Byrna Technologies Inc.Miscellaneous Electrical Machinery, Equipment & Supplies
- ENR · ENERGIZER HOLDINGS, INC.Miscellaneous Electrical Machinery, Equipment & Supplies
- ENVX · Enovix CorpMiscellaneous Electrical Machinery, Equipment & Supplies
- EOSE · Eos Energy Enterprises, Inc.Miscellaneous Electrical Machinery, Equipment & Supplies
- FLNC · Fluence Energy, Inc.Miscellaneous Electrical Machinery, Equipment & Supplies
- MVST · Microvast Holdings, Inc.Miscellaneous Electrical Machinery, Equipment & Supplies
- SLDP · Solid Power, Inc.Miscellaneous Electrical Machinery, Equipment & Supplies
- SPB · Spectrum Brands Holdings, Inc.Miscellaneous Electrical Machinery, Equipment & Supplies
NOVT SEC filings: frequently asked questions
Are NOVT insiders buying or selling?
In the last 90 days, NOVANTA INC (NOVT) officers, directors and 10% owners reported no open-market purchases and 1 open-market sale worth $97,859 by 1 insider on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold NOVT stock?
As of September 30, 2026, the largest NOVANTA INC (NOVT) holders among the 13F filers tracked by SignalX were BlackRock ($701.2 million), Vanguard Portfolio Management LLC ($343.3 million), T. Rowe Price Group ($292.2 million), Vanguard Capital Management LLC ($241.3 million), State Street Corp ($210.4 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was NOVT's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), NOVANTA INC (NOVT) reported revenue of $980.6 million (up 3.3% from FY2024) and net income of $53.8 million. Diluted EPS was $1.47. The figures come from the XBRL data in the 10-K.
What are the main risks in NOVT's latest 10-K?
In the 10-K filed February 23, 2026, NOVANTA INC (NOVT) flagged: Regulatory/legal risk: Restrictions on dividends and asset transfers from foreign subsidiaries under local laws impacting funding for parent operations. Geopolitical/macro risk: $67.6M cash and $74M debt held by non-North American subsidiaries, limiting capital repatriation flexibility. (AI summary of the Risk Factors section.)
What did NOVT report in its latest 8-K?
NOVANTA INC (NOVT) filed an 8-K on November 9, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Novanta announced fiscal Q3 2026 financial results for the quarter ended October 2, 2026.
What are the latest NOVT SEC filings?
NOVANTA INC (NOVT) filed its latest 10-K annual report on February 23, 2026, a 10-Q quarterly report on November 9, 2026, an 8-K current report on November 9, 2026 and a Form 4 insider filing on November 5, 2026.
What is NOVT's SEC CIK number?
NOVANTA INC (NOVT)'s SEC Central Index Key (CIK) is 1076930. EDGAR lists every NOVT filing under that number.
Ask anything about NOVT
The research agent reads NOVT's filings, financials, insider trades and 13F holders, then answers with sources.